- Home
- IKT vs GECC Comparison
IKT vs GECC Comparison
Compare IKT & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- GECC
- Stock Information
- Founded
- IKT 2008
- GECC 2016
- Country
- IKT United States
- GECC United States
- Employees
- IKT N/A
- GECC N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- GECC Finance: Consumer Services
- Sector
- IKT Health Care
- GECC Finance
- Exchange
- IKT Nasdaq
- GECC Nasdaq
- Market Cap
- IKT 140.5M
- GECC 123.1M
- IPO Year
- IKT 2020
- GECC N/A
- Fundamental
- Price
- IKT $1.85
- GECC $10.94
- Analyst Decision
- IKT Buy
- GECC
- Analyst Count
- IKT 2
- GECC 0
- Target Price
- IKT $8.00
- GECC N/A
- AVG Volume (30 Days)
- IKT 526.2K
- GECC 25.1K
- Earning Date
- IKT 08-13-2025
- GECC 07-31-2025
- Dividend Yield
- IKT N/A
- GECC 13.97%
- EPS Growth
- IKT N/A
- GECC N/A
- EPS
- IKT N/A
- GECC 0.42
- Revenue
- IKT N/A
- GECC $42,909,000.00
- Revenue This Year
- IKT N/A
- GECC $32.54
- Revenue Next Year
- IKT N/A
- GECC N/A
- P/E Ratio
- IKT N/A
- GECC $25.92
- Revenue Growth
- IKT N/A
- GECC 18.13
- 52 Week Low
- IKT $1.12
- GECC $8.87
- 52 Week High
- IKT $4.20
- GECC $11.39
- Technical
- Relative Strength Index (RSI)
- IKT 47.71
- GECC 58.09
- Support Level
- IKT $1.80
- GECC $10.83
- Resistance Level
- IKT $2.09
- GECC $10.60
- Average True Range (ATR)
- IKT 0.14
- GECC 0.19
- MACD
- IKT 0.03
- GECC 0.03
- Stochastic Oscillator
- IKT 54.72
- GECC 100.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.